Skip to main content

Table 3 The ABCB1 C3435T polymorphism on lipid-lowering therapy

From: ABCB1 C3435T polymorphism and the lipid-lowering response in hypercholesterolemic patients on statins: a meta-analysis

 

CC vs. CT+TT

CC+CT vs. TT

CC vs. TT

Variables

OR (95 % CI)

Pa

P

OR (95 % CI)

Pa

P

OR (95 % CI)

Pa

P

TC

1.36(−0.24,2.95)

0.64

0.09

1.33(−0.11,2.77)

0.45

0.07

2.29(0.37,4.20)

0.76

0.02

HDL-C

0.81(−1.48,3.11)

0.62

0.49

2.46(0.36,4.55)

0.25

0.02

2.44(−0.35,5.24)

0.39

0.09

LDL-C

1.79(−0.24,3.83)

0.31

0.08

1.31(−0.56,3.18)

0.29

0.17

3.05(0.58,5.53)

0.72

0.02

TG

0.10(−3.99,4.18)

0.96

0.96

1.14(−2.97,5.26)

0.84

0.59

1.51(−3.68,6.70)

0.91

0.57

  1. a p value of Q-test for heterogeneity test